MILAN, March 10, 2025 (GLOBE NEWSWIRE) — AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company, today announces the publication of two abstracts submitted to The Association for Research in Vision and Ophthalmology Annual Meeting (ARVO), to be held May 4-8, 2025 in Salt Lake City (US).
The oral presentation from the LUCE-1 clinical trial in Usher 1B builds on the data presented at the FLORetina medical conference in December 2024 with updates from more patients dosed since then, and will be presented by AAVantgarde’s Principal Investigator, Prof. Francesca Simonelli, Head of the Ophthalmology Unit at the University Hospital of Campania “Luigi Vanvitelli” (Naples).
The poster presentation from AAVantgarde’s Stargardt program will report preliminary …
